MERIBANKBIOTECH monthly revenue
MERIBANKBIOTECH
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0B | +5.8% | -29.9% | NT$0.2B |
| May 2026 | Jun 17, 2026 | NT$0B | -11.2% | -34.3% | NT$0.2B |
| Apr 2026 | May 17, 2026 | NT$0B | -6.5% | -27.7% | NT$0.1B |
| Mar 2026 | Apr 17, 2026 | NT$0B | +1.5% | -20.5% | NT$0.1B |
| Feb 2026 | Mar 17, 2026 | NT$0B | -10.7% | -23.6% | NT$0.1B |
| Jan 2026 | — | NT$0B | — | -16.1% | NT$0B |
| Dec 2025 | — | NT$0B | — | -28.5% | NT$0.5B |
| Nov 2025 | — | NT$0B | — | -13.5% | NT$0.4B |
| Oct 2025 | — | NT$0B | — | -12.3% | NT$0.4B |
| Sep 2025 | — | NT$0B | — | +0.1% | NT$0.4B |
| Aug 2025 | — | NT$0B | — | +3.6% | NT$0.3B |
| Jul 2025 | — | NT$0B | — | +28.5% | NT$0.3B |
| Jun 2025 | — | NT$0B | — | +93.9% | NT$0.3B |
| May 2025 | — | NT$0B | — | +63.3% | NT$0.2B |
| Apr 2025 | — | NT$0B | — | +80.8% | NT$0.2B |
| Mar 2025 | — | NT$0B | — | +85.5% | NT$0.1B |
| Feb 2025 | — | NT$0B | — | +151.0% | NT$0.1B |
| Jan 2025 | — | NT$0B | — | +97.6% | NT$0B |
| Dec 2024 | — | NT$0.1B | — | +125.4% | NT$0.4B |
| Nov 2024 | — | NT$0B | — | +65.1% | NT$0.3B |
| Oct 2024 | — | NT$0B | — | +95.2% | NT$0.3B |
| Sep 2024 | — | NT$0B | — | +60.9% | NT$0.2B |
| Aug 2024 | — | NT$0B | — | +81.0% | NT$0.2B |
| Jul 2024 | — | NT$0B | — | +52.3% | NT$0.2B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-03-23. Source: Taiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.